Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. McVie J G: DNA topoisomerases in cancer treatment.Br Med J
296, 1145 (1988).
2. European Organization for Research on the Treatment of Cancer, Clinical Screening Group: Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.Br Med J
3, 199 (1973).
3. Mathé G, Schwarzenberg L, Pouillart R,et al.: Two epipodophyllotoxin derivatives. VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.Cancer
34, 985 (1974).
4. Smith I E, Gerken M E, Clink H M, McElwain T J: VP 16-213 in acute myelogenous leukemia.Postgrad Med J
52, 66 (1976).
5. Rivera G, Avery T, Pratt C: 4′-Demethylepipodophyllotoxin 9-(4,6-0-2-thenylidine-ß-D-glucopyranoside) (NSC-122819; VM-26) and 4′-demethylepipodophyllotoxin 9-(4-6-0-ethylidine-ß-D-glucopyranoside) (NSC-141540; VP 16-213) in childhood cancer: preliminary observations.Cancer Chemother Rep
59, 743 (1975).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献